BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Market Cap	121.74B
Revenue (ttm)	16.07B
Net Income (ttm)	5.10B
Shares Out	8.70M
EPS (ttm)	598.10
PE Ratio	23.41
Forward PE	21.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,219
Average Volume	18,772
Open	14,010
Previous Close	14,010
Day's Range	13,920 - 14,160
52-Week Range	12,100 - 19,150
Beta	0.58
RSI	52.23
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, herbal extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, skin moisturizing, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 251120

Financial Performance

In 2023, BIO-FD&C's revenue was 15.59 billion, a decrease of -1.66% compared to the previous year's 15.86 billion. Earnings were 5.59 billion, an increase of 28.83%.